Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design.
Pandemic (H1N1) influenza poses an imminent threat. Nations have stockpiled inhibitors of the influenza protein neuraminidase in hopes of protecting their citizens, but drug-resistant strains have already emerged, and novel therapeutics are urgently needed. In the current work, the computer program AutoGrow is used to generate novel predicted neuraminidase inhibitors. Given the great flexibility of the neuraminidase active site, protein dynamics are also incorporated into the computer-aided drug-design process. Several potential inhibitors are identified that are predicted to bind to neuraminidase better than currently approved drugs.
Durrant
Jacob D
JD
Biomedical Sciences Program, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0365, United States. jdurrant@ucsd.edu
McCammon
J Andrew
JA
D000998:Antiviral Agents / Q000737:chemistry*; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000737:chemistry*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000201:enzymology*; D007251:Influenza, Human / Q000188:drug therapy; D056004:Molecular Dynamics Simulation; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000737:chemistry*
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D009439:Neuraminidase